Zealand Pharma and Pepscan awarded EU grant of EUR 0.9 million for the joint development of peptide drugs
24-Mar-2011
- Netherlands
The grant awarded to Zealand Pharma and Pepscan covers a two-year development period, which is expected to lead to the identification of a lead dual acting peptide drug candidate ready for preclinical development.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.